Literature DB >> 9195287

Angiogenic factors as tumor markers.

M Nguyen1.   

Abstract

The process of angiogenesis plays a critical role in tumor growth and metastasis. Recently, there has been much interest in the possible use of angiogenic growth factors as tumor markers. This paper will review the results thus far of attempts at measuring various angiogenic factors in bodily fluids. In the future, angiogenic factors will most likely be useful as a monitor of therapy and/or a predictor of outcome after cancer has been diagnosed.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9195287     DOI： 10.1023/a:1005766511385

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


  40 in total

1.  The impact of iatrogenic urothelial trauma on urinary levels of transforming growth factor-alpha.

Authors:  C S Cooper; W A See
Journal:  J Urol       Date:  1992-06       Impact factor: 7.450

2.  Increased serum levels of basic fibroblast growth factor in patients with renal cell carcinoma.

Authors:  K Fujimoto; Y Ichimori; T Kakizoe; E Okajima; H Sakamoto; T Sugimura; M Terada
Journal:  Biochem Biophys Res Commun       Date:  1991-10-15       Impact factor: 3.575

3.  Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1.

Authors:  A E Koch; M M Halloran; C J Haskell; M R Shah; P J Polverini
Journal:  Nature       Date:  1995-08-10       Impact factor: 49.962

4.  Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers.

Authors:  M Nguyen; H Watanabe; A E Budson; J P Richie; D F Hayes; J Folkman
Journal:  J Natl Cancer Inst       Date:  1994-03-02       Impact factor: 13.506

5.  Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophy.

Authors:  T S O'Brien; K Smith; D Cranston; S Fuggle; R Bicknell; A L Harris
Journal:  Br J Urol       Date:  1995-09

6.  Urinary epidermal growth factor in patients with gliomas: significance of the factor as a glial tumor marker.

Authors:  H Kanno; Y Chiba; Y Kyuma; A Hayashi; H Abe; H Takada; I Kim; I Yamamoto
Journal:  J Neurosurg       Date:  1993-09       Impact factor: 5.115

7.  Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours.

Authors:  V W Li; R D Folkerth; H Watanabe; C Yu; M Rupnick; P Barnes; R M Scott; P M Black; S E Sallan; J Folkman
Journal:  Lancet       Date:  1994-07-09       Impact factor: 79.321

8.  Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis.

Authors:  T Ueda; E Shimada; T Urakawa
Journal:  J Gastroenterol       Date:  1994-08       Impact factor: 7.527

9.  Serum levels of transforming growth factor alpha in gastrointestinal cancer patients.

Authors:  T L Moskal; S Huang; L M Ellis; H A Fritsche; S Chakrabarty
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1995-03       Impact factor: 4.254

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245
View more
  15 in total

Review 1.  Positron emission tomography imaging of cancer biology: current status and future prospects.

Authors:  Kai Chen; Xiaoyuan Chen
Journal:  Semin Oncol       Date:  2011-02       Impact factor: 4.929

2.  Isolation and proteomic analysis of platelets by SELDI-TOF MS.

Authors:  Sean R Downing; Giannoula L Klement
Journal:  Methods Mol Biol       Date:  2012

3.  Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.

Authors:  Francisco das Chagas Abreu da Silveira; Bruno de Almeida Lopes; Clovis Orlando da Fonseca; Thereza Quirico-Santos; Izabel Christina Nunes de Palmer Paixão; Lidia Maria da Fonte de Amorim
Journal:  J Cancer Res Clin Oncol       Date:  2012-04-06       Impact factor: 4.553

4.  Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings.

Authors:  Edward R Sauter; Colette Wagner-Mann; Hormoz Ehya; Andres Klein-Szanto
Journal:  Cancer Detect Prev       Date:  2007-02-20

Review 5.  Preclinical molecular imaging of tumor angiogenesis.

Authors:  L Zhu; G Niu; X Fang; X Chen
Journal:  Q J Nucl Med Mol Imaging       Date:  2010-06       Impact factor: 2.346

6.  Angiogenesis: Future of pharmacological modulation.

Authors:  Manisha Bisht; D C Dhasmana; S S Bist
Journal:  Indian J Pharmacol       Date:  2010-02       Impact factor: 1.200

7.  Salivary protein factors are elevated in breast cancer patients.

Authors:  Mai N Brooks; Jianghua Wang; Yang Li; Rong Zhang; David Elashoff; David T Wong
Journal:  Mol Med Rep       Date:  2008 May-Jun       Impact factor: 2.952

8.  PET Imaging of Angiogenesis.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  PET Clin       Date:  2009-01-01

Review 9.  Vascular endothelial growth factor as an anti-angiogenic target for cancer therapy.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  Curr Drug Targets       Date:  2010-08       Impact factor: 3.465

10.  Tumor angiogenesis as a target for dietary cancer prevention.

Authors:  William W Li; Vincent W Li; Michelle Hutnik; Albert S Chiou
Journal:  J Oncol       Date:  2011-09-29       Impact factor: 4.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.